PAOLETTA, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 901
AS - Asia 284
EU - Europa 216
AF - Africa 63
SA - Sud America 56
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 1.529
Nazione #
US - Stati Uniti d'America 867
SG - Singapore 95
CN - Cina 58
IT - Italia 38
BR - Brasile 37
HK - Hong Kong 37
VN - Vietnam 30
DE - Germania 24
FI - Finlandia 20
FR - Francia 15
NL - Olanda 15
GB - Regno Unito 13
UA - Ucraina 13
IN - India 10
PL - Polonia 9
SE - Svezia 9
RU - Federazione Russa 8
MX - Messico 6
AT - Austria 5
IE - Irlanda 5
MK - Macedonia 5
PK - Pakistan 5
PY - Paraguay 5
AR - Argentina 4
CW - ???statistics.table.value.countryCode.CW??? 4
CY - Cipro 4
EE - Estonia 4
MN - Mongolia 4
SO - Somalia 4
TR - Turchia 4
CO - Colombia 3
DZ - Algeria 3
EG - Egitto 3
GN - Guinea 3
GR - Grecia 3
GT - Guatemala 3
IQ - Iraq 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
MD - Moldavia 3
MG - Madagascar 3
MW - Malawi 3
NO - Norvegia 3
PA - Panama 3
TN - Tunisia 3
TZ - Tanzania 3
VC - Saint Vincent e Grenadine 3
ZW - Zimbabwe 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
BG - Bulgaria 2
BW - Botswana 2
CA - Canada 2
CD - Congo 2
CI - Costa d'Avorio 2
CM - Camerun 2
CU - Cuba 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ES - Italia 2
GF - Guiana Francese 2
GH - Ghana 2
HN - Honduras 2
HU - Ungheria 2
ID - Indonesia 2
IL - Israele 2
LC - Santa Lucia 2
LV - Lettonia 2
MA - Marocco 2
NE - Niger 2
NP - Nepal 2
NR - Nauru 2
PE - Perù 2
RE - Reunion 2
RO - Romania 2
RS - Serbia 2
RW - Ruanda 2
SD - Sudan 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UZ - Uzbekistan 2
YT - Mayotte 2
ZA - Sudafrica 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
Totale 1.504
Città #
Fairfield 142
Houston 84
Ashburn 69
Woodbridge 56
Santa Clara 54
Seattle 54
Singapore 52
Chandler 48
Cambridge 45
Jacksonville 45
Wilmington 42
Hong Kong 37
Ann Arbor 21
Boardman 20
Beijing 18
Dong Ket 18
Princeton 18
San Diego 15
Des Moines 10
Roxbury 10
Ho Chi Minh City 8
Medford 8
Munich 8
Bytom 7
Nanjing 7
Cagliari 6
Helsinki 6
Skopje 5
Columbus 4
Council Bluffs 4
Dublin 4
Florence 4
Novara 4
Willemstad 4
Antananarivo 3
Belo Horizonte 3
Chennai 3
Ciudad del Este 3
Conakry 3
Dallas 3
Dar es Salaam 3
Guatemala City 3
Harare 3
Kingstown 3
Panama City 3
Rome 3
Tallinn 3
Turku 3
Ulan Bator 3
Vienna 3
Vientiane 3
Abidjan 2
Accra 2
Asunción 2
Athens 2
Atlanta 2
Belgrade 2
Borama 2
Castries 2
Changsha 2
Contagem 2
Curitiba 2
Douala 2
Dushanbe 2
Ferrara 2
Gaborone 2
Hefei 2
Indaiatuba 2
Istanbul 2
Jiaxing 2
Johannesburg 2
Kathmandu 2
Khartoum 2
Kigali 2
Kinshasa 2
La Ceiba 2
Lahore 2
Lanzhou 2
Lilongwe 2
Lima 2
Limassol 2
London 2
Los Angeles 2
Luanda 2
Mamoudzou 2
Moscow 2
Naples 2
New York 2
Norwalk 2
Ogden 2
Padova 2
Pilāni 2
Port of Spain 2
Rio de Janeiro 2
Santo Domingo 2
Shenyang 2
Shibīn al Kawm 2
Sulaymaniyah 2
São Paulo 2
Tashkent 2
Totale 1.086
Nome #
The Significance of 2-Furyl Ring Substitution with a 2-(para-substituted) Aryl Group in a New Series of Pyrazolo-triazolo-pyrimidines as Potent and Highly Selective hA(3) Adenosine Receptors Antagonists: New Insights into Structure-Affinity Relationship and Receptor-Antagonist Recognition 147
A Novel Generalized 3D-QSAR Model of Camptothecin Analogs 146
Designing adenosine receptors antagonists using an in silico approach 144
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A(3) Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition 131
Revisiting a Receptor-Based Pharmacophore Hypothesis for Human A2AAdenosine Receptor Antagonists 127
Pyrazolo[4,3-: E] [1,2,4]triazolo[1,5-c] pyrimidines to develop functionalized ligands to target adenosine receptors: Fluorescent ligands as an example 125
Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: A preliminary inspection of ligand-receptor recognition process 121
Fluorescent ligands for adenosine receptors 107
Exploring the Directionality of 5-Substitutions in a New Series of 5-Alkylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine as a Strategy To Design Novel Human A3Adenosine Receptor Antagonists. 105
Discovery of novel A3 adenosine receptor ligands based on chromone scaffold. 104
Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometry. 100
Synthesis and pharmacological characterization of a new series of 5,7-disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazine derivatives as adenosine receptor antagonists: a preliminary receptor-driven SAR profile 94
The Identification of the 2-Phenylphthalazin-1(2H)-one Scaffold as a New Decorable Core Skeleton for the Design of Potent and Selective Human A(3) Adenosine Receptor Antagonists 80
Totale 1.531
Categoria #
all - tutte 5.843
article - articoli 5.258
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.101


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021104 0 0 0 11 2 13 1 11 20 7 16 23
2021/2022175 7 20 32 6 3 2 9 25 3 7 27 34
2022/2023121 24 2 0 6 28 28 0 9 13 1 8 2
2023/2024116 3 15 17 12 12 12 2 18 4 3 12 6
2024/2025343 0 12 10 20 70 14 11 27 25 19 59 76
2025/2026268 24 87 156 1 0 0 0 0 0 0 0 0
Totale 1.531